Divis Lab reported a strong 26% rise in Q1FY24 consolidated net profit.
Divis Laboratories, a pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) and Intermediates, released its Q1FY24 financial results, showcasing notable performance in various aspects. Here's an analysis…